242 related articles for article (PubMed ID: 25131592)
1. Oligomers of α-synuclein: picking the culprit in the line-up.
Lorenzen N; Otzen DE
Essays Biochem; 2014; 56():137-48. PubMed ID: 25131592
[TBL] [Abstract][Full Text] [Related]
2. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
[TBL] [Abstract][Full Text] [Related]
3. Modulation of α-synuclein fibrillization by ring-fused 2-pyridones: templation and inhibition involve oligomers with different structure.
Horvath I; Sellstedt M; Weise C; Nordvall LM; Krishna Prasad G; Olofsson A; Larsson G; Almqvist F; Wittung-Stafshede P
Arch Biochem Biophys; 2013 Apr; 532(2):84-90. PubMed ID: 23399432
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity.
Lam HT; Graber MC; Gentry KA; Bieschke J
Biochemistry; 2016 Feb; 55(4):675-85. PubMed ID: 26799377
[TBL] [Abstract][Full Text] [Related]
5. N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism.
Watson MD; Lee JC
Biochemistry; 2019 Sep; 58(35):3630-3633. PubMed ID: 31424918
[TBL] [Abstract][Full Text] [Related]
6. Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein.
Gallea JI; Sarroukh R; Yunes-Quartino P; Ruysschaert JM; Raussens V; Celej MS
Biochim Biophys Acta; 2016 May; 1864(5):501-10. PubMed ID: 26845568
[TBL] [Abstract][Full Text] [Related]
7. Small molecule-mediated stabilization of vesicle-associated helical α-synuclein inhibits pathogenic misfolding and aggregation.
Fonseca-Ornelas L; Eisbach SE; Paulat M; Giller K; Fernández CO; Outeiro TF; Becker S; Zweckstetter M
Nat Commun; 2014 Dec; 5():5857. PubMed ID: 25524885
[TBL] [Abstract][Full Text] [Related]
8. Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.
Palazzi L; Fongaro B; Leri M; Acquasaliente L; Stefani M; Bucciantini M; Polverino de Laureto P
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199427
[TBL] [Abstract][Full Text] [Related]
9. Small-Molecule-Induced Soluble Oligomers of α-Synuclein with Helical Structure.
Fonseca-Ornelas L; Schmidt C; Camacho-Zarco AR; Fernandez CO; Becker S; Zweckstetter M
Chemistry; 2017 Sep; 23(53):13010-13014. PubMed ID: 28763125
[TBL] [Abstract][Full Text] [Related]
10. The N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers.
Drew SC
Chemistry; 2015 May; 21(19):7111-8. PubMed ID: 25757154
[TBL] [Abstract][Full Text] [Related]
11. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
Jiang C; Chang JY
Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570
[TBL] [Abstract][Full Text] [Related]
12. DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein.
Atieh TB; Roth J; Yang X; Hoop CL; Baum J
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680099
[TBL] [Abstract][Full Text] [Related]
13. Polypeptides derived from α-Synuclein binding partners to prevent α-Synuclein fibrils interaction with and take-up by cells.
Monsellier E; Bendifallah M; Redeker V; Melki R
PLoS One; 2020; 15(8):e0237328. PubMed ID: 32790707
[TBL] [Abstract][Full Text] [Related]
14. High stability and cooperative unfolding of α-synuclein oligomers.
Paslawski W; Andreasen M; Nielsen SB; Lorenzen N; Thomsen K; Kaspersen JD; Pedersen JS; Otzen DE
Biochemistry; 2014 Oct; 53(39):6252-63. PubMed ID: 25216651
[TBL] [Abstract][Full Text] [Related]
15. The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes.
Lorenzen N; Lemminger L; Pedersen JN; Nielsen SB; Otzen DE
FEBS Lett; 2014 Jan; 588(3):497-502. PubMed ID: 24374342
[TBL] [Abstract][Full Text] [Related]
16. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
[TBL] [Abstract][Full Text] [Related]
17. Dopamine quinones interact with alpha-synuclein to form unstructured adducts.
Bisaglia M; Tosatto L; Munari F; Tessari I; de Laureto PP; Mammi S; Bubacco L
Biochem Biophys Res Commun; 2010 Apr; 394(2):424-8. PubMed ID: 20226175
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein oligomers: a new hope.
Bengoa-Vergniory N; Roberts RF; Wade-Martins R; Alegre-Abarrategui J
Acta Neuropathol; 2017 Dec; 134(6):819-838. PubMed ID: 28803412
[TBL] [Abstract][Full Text] [Related]
19. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
[TBL] [Abstract][Full Text] [Related]
20. The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates α-synuclein aggregation and membrane binding.
Ghosh D; Sahay S; Ranjan P; Salot S; Mohite GM; Singh PK; Dwivedi S; Carvalho E; Banerjee R; Kumar A; Maji SK
Biochemistry; 2014 Oct; 53(41):6419-21. PubMed ID: 25268550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]